» Articles » PMID: 38279024

Hypoxia-driven DeSUMOylation of EXOSC10 Promotes Adaptive Changes in the Transcriptome Profile

Overview
Publisher Springer
Specialty Biology
Date 2024 Jan 26
PMID 38279024
Authors
Affiliations
Soon will be listed here.
Abstract

Reduced oxygen availability (hypoxia) triggers adaptive cellular responses via hypoxia-inducible factor (HIF)-dependent transcriptional activation. Adaptation to hypoxia also involves transcription-independent processes like post-translational modifications; however, these mechanisms are poorly characterized. Investigating the involvement of protein SUMOylation in response to hypoxia, we discovered that hypoxia strongly decreases the SUMOylation of Exosome subunit 10 (EXOSC10), the catalytic subunit of the RNA exosome, in an HIF-independent manner. EXOSC10 is a multifunctional exoribonuclease enriched in the nucleolus that mediates the processing and degradation of various RNA species. We demonstrate that the ubiquitin-specific protease 36 (USP36) SUMOylates EXOSC10 and we reveal SUMO1/sentrin-specific peptidase 3 (SENP3) as the enzyme-mediating deSUMOylation of EXOSC10. Under hypoxia, EXOSC10 dissociates from USP36 and translocates from the nucleolus to the nucleoplasm concomitant with its deSUMOylation. Loss of EXOSC10 SUMOylation does not detectably affect rRNA maturation but affects the mRNA transcriptome by modulating the expression levels of hypoxia-related genes. Our data suggest that dynamic modulation of EXOSC10 SUMOylation and localization under hypoxia regulates the RNA degradation machinery to facilitate cellular adaptation to low oxygen conditions.

Citing Articles

Defining gene ends: RNA polymerase II CTD threonine 4 phosphorylation marks transcription termination regions genome-wide.

Kopczynska M, Saha U, Romanenko A, Nojima T, Gdula M, Kamieniarz-Gdula K Nucleic Acids Res. 2024; 53(2.

PMID: 39718990 PMC: 11754735. DOI: 10.1093/nar/gkae1240.


Hypoxia and the endometrium: An indispensable role for HIF-1α as therapeutic strategies.

Dai W, Guo R, Na X, Jiang S, Liang J, Guo C Redox Biol. 2024; 73:103205.

PMID: 38815332 PMC: 11167393. DOI: 10.1016/j.redox.2024.103205.


The Emerging Role of Ubiquitin-Specific Protease 36 (USP36) in Cancer and Beyond.

Niu M, Liu Y, Shi J, Chen R, Zhang S, Li C Biomolecules. 2024; 14(5).

PMID: 38785979 PMC: 11118191. DOI: 10.3390/biom14050572.

References
1.
Chachami G, Stankovic-Valentin N, Karagiota A, Basagianni A, Plessmann U, Urlaub H . Hypoxia-induced Changes in SUMO Conjugation Affect Transcriptional Regulation Under Low Oxygen. Mol Cell Proteomics. 2019; 18(6):1197-1209. PMC: 6553927. DOI: 10.1074/mcp.RA119.001401. View

2.
Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001; 411(6836):494-8. DOI: 10.1038/35078107. View

3.
Raman N, Nayak A, Muller S . mTOR signaling regulates nucleolar targeting of the SUMO-specific isopeptidase SENP3. Mol Cell Biol. 2014; 34(24):4474-84. PMC: 4248736. DOI: 10.1128/MCB.00801-14. View

4.
Hendriks I, Vertegaal A . A high-yield double-purification proteomics strategy for the identification of SUMO sites. Nat Protoc. 2016; 11(9):1630-49. DOI: 10.1038/nprot.2016.082. View

5.
Goldberg-Cohen I, Furneauxb H, Levy A . A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J Biol Chem. 2002; 277(16):13635-40. DOI: 10.1074/jbc.M108703200. View